{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88475",
      "recalling_firm": "Granules USA, Inc.",
      "address_1": "35 Waterview Blvd Fl 3",
      "address_2": "N/A",
      "postal_code": "07054-1200",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "NY",
      "recall_number": "D-0777-2021",
      "product_description": "Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules  India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village,   Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043,  Telangana, INDIA. NDC 62207-762-36",
      "product_quantity": "11,450,000 tablets",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20210811",
      "center_classification_date": "20210827",
      "termination_date": "20230216",
      "report_date": "20210908",
      "code_info": "7620060a"
    }
  ]
}